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Four calves were experimentally inoculated with 
highly pathogenic avian inﬂ  uenza  virus  A/cat/Germany/
R606/2006 (H5N1) isolated from a cat in 2006. All calves 
remained healthy, but several animals shed low amounts 
of virus, detected by inoculation of nasal swab ﬂ  uid into 
embryonated chicken eggs and onto MDCK cells. All 
calves seroconverted. 
S
ince 1997, an epidemic of highly pathogenic avian in-
ﬂ  uenza virus (HPAIV) subtype H5N1 has spread in 
Asia, causing fatal infections in poultry, wild birds, and 
mammals, including humans (1). Knowing the suscepti-
bility to HPAIV (H5N1) of mammalian species living in 
close proximity to humans and poultry, such as members of 
the family Bovidae (e.g., cattle or water buffalo), would be 
helpful to those developing surveillance plans or determin-
ing risk areas. Serologic examinations have indicated that 
calves might be susceptible to inﬂ  uenza A virus (2); how-
ever, so far only 1 strain (A/calf/Duschanbe/55/71 H3N2) 
has been identiﬁ  ed as a cattle strain (3). A correlation be-
tween inﬂ  uenza A virus infection, reduced milk yield, and 
respiratory symptoms in dairy cows was assumed in the late 
1990s (4,5) and has received recent attention (6,7). Never-
theless, to our knowledge, no data about the susceptibil-
ity of cattle to infections with HPAIV have been reported. 
Therefore, we experimentally infected bovine calves with 
HPAIV (H5N1) and collected data about clinical symp-
toms, viral excretion, and serologic reactions. 
The Study
In 2007, 6 Holstein-Friesian calves, 3 month of age, 
were obtained from a breeder near Greifswald-Insel Riems, 
Germany. Their inﬂ  uenza A virus–free status was con-
ﬁ  rmed, and no avian inﬂ  uenza virus–speciﬁ  c genomes or 
antibodies were detected. All experiments were performed 
in the high-containment animal facility (Biosafety Level 
3+) at the Friedrich-Loefﬂ   er-Institut (trial approval no. 
LVLM-V/TSD/7221.3-1.1-003/07). 
Four of the calves were intranasally inoculated with 
HPAIV (H5N1) strain A/cat/Germany/R606/2006, which 
had been isolated from a cat in 2006 (8,9). The virus was 
aerosolized in 5 mL cell culture medium containing 108.5 
50% egg infectious dose/mL (third egg passage). The other 
2 calves (contacts) were not inoculated but were housed 
in the same containment room for the duration of the ex-
periment. For 7 days all calves were monitored by physi-
cal examination, and pharyngeal swabs were collected and 
examined for virus excretion.
All 6 calves remained healthy; no speciﬁ  c  clinical 
signs were observed. All nasal swabs were tested with real-
time reverse transcription–PCR speciﬁ  c for subtype H5N1 
(10), and the genomic load was semiquantiﬁ  ed by using 
threshold cycle values. Infectious virus was detected by 
inoculation of swab ﬂ  uid into embryonated chicken eggs 
with 1 subsequent passage and onto MDCK cells (collec-
tion of cell lines in veterinary medicine, Friedrich-Loefﬂ  er-
Institut, Isle of Riems, RIE83).
Nasal swabs from all inoculated calves collected at 1 
day postinoculation (dpi) were positive for viral RNA, and 3 
of 4 calves shed infectious virus, detected by virus isolation 
in embryonated chicken eggs (Table 1). Isolation of infec-
tious virus in cell culture was successful in 2 of 4 samples. 
Furthermore, of 4 inoculated calves, 2 were positive for 
HPAIV (H5N1) genome copies at 2 dpi, and 1 shed infec-
tious virus. From 3 dpi through 7 dpi, samples from nasal 
swabs of all animals were negative for viral genome, and all 
nasal swabs of the 2 contact calves remained negative for 
HPAIV (H5N1) RNA during the experiment (Table 1).
Assuming that susceptible animals should mount an 
antibody response, we looked for antibodies against the 
highly conserved and immunogenic nucleoprotein (NP) of 
type A inﬂ  uenza viruses (11). Heat-inactivated (30 min at 
56°C) serum samples collected at 0, 7, 14, 21, 28, and 91 
dpi were tested for NP-speciﬁ  c antibodies with a licensed 
commercial ELISA (avian inﬂ  uenza A–blocking ELISA, 
Pourquier, Montpellier, France)  according to the manu-
facturer’s instructions. Serum samples from 50 HPAIV 
(H5N1)–negative, nonrelated cattle were used as con-
trols and to conﬁ  rm the speciﬁ  city of the ELISA (data not 
shown). 
To quantify the serologic response, we performed virus 
neutralization (VN) and hemagglutination inhibition (HI) 
tests with homotypic virus. The VN test was modiﬁ  ed ac-
cording to a previously described procedure (12). In brief, 
bovine serum samples were heat inactivated for 30 min at 
56°C, and 3-fold serial dilutions were performed in a 50-μL 
volume of cell culture medium in 96-well plates. The dilut-
ed serum samples were mixed with an equal volume of me-
dia containing homotypic inﬂ  uenza virus at a concentration 
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of 102 50% tissue culture infectious dose/well. After 1 h in-
cubation at 37°C in a 5% CO2 humidiﬁ  ed atmosphere, 100 
μL of Vero cells (African green monkey kidney, collection 
of cell lines in veterinary medicine, Friedrich-Loefﬂ  er-In-
stitut, Isle of Riems, RIE228) at 1.5 × 105/mL was added to 
each well. The plates were incubated for 3 days at 37°C and 
5% CO2. Viral replication was assessed by visually scor-
ing the cytopathic effect without staining. Each assay was 
validated by comparison with positive and negative control 
serum from chickens and cattle as well as back titration 
of the used virus dilutions. Previous treatment with perio-
date (13) had no inﬂ  uence on the neutralizing titers. Serum 
samples were also tested for H5-speciﬁ  c antibodies by HI 
test with 4 hemagglutinating units of homotypic virus as 
antigen according to standardized methods (14). All serum 
samples were treated with periodate and heat inactivated 
to eliminate serum inhibitors. The HI tests were performed 
with a starting dilution of 1:8 by using a 1% suspension of 
chicken erythrocytes in a 0.85% saline solution.
The commercial NP-speciﬁ  c ELISA detected inﬂ  uen-
za A virus–speciﬁ  c antibodies at 14 dpi in 2 of the 4 inocu-
lated animals (Table 2). All 4 animals had positive scores 
for neutralizing antibodies against the homologous virus at 
14 dpi; speciﬁ  c titers ranged from 16 to 51. Furthermore, 
the HI test detected titers of 8 at 28 dpi in the 4 inoculated 
calves. At 21 dpi, VN testing indicated that 1 of the contact 
calves was positive for subtype H5N1–speciﬁ  c antibodies, 
NP-ELISA results for this calf were questionable, and HI 
testing did not detect any hemagglutinating antibodies. The 
other contact calf remained serologically negative through-
out the experiment. Finally, 3 months after inoculation, 
VN test and ELISA clearly indicated seroconversion by all 
inoculated calves and 1 of the contact calves. In contrast, 
HI results were negative for all but 2 inoculated animals 
(Table 2).
Conclusions
Our ﬁ  ndings show that HPAIV (H5N1) has the po-
tential to infect bovine calves, at least after high-titer in-
tranasal inoculation, and that conventional HI tests may 
underestimate such infections. Furthermore, asymptomatic 
shedding of HPAIV (H5N1) by infected calves and subse-
quent seroconversion seem to be possible, and even low 
levels of HPAIV (H5N1) might be sufﬁ  cient to induce a 
detectable antibody response in contact calves. However, 
the possibility that the infectivity detected in the contact 
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Table 1. Detection of highly pathogenic avian influenza virus (H5N1) in nasal swabs from calves, Germany, 2007* 
Day postinoculation 
0 1 2 3–7
Calf PCR† PCR Egg Cell PCR Egg Cell PCR
Inoculated
 A1  >40 20–30 – – 30–40 – – >40
 A2  >40 30–40 + + 30–40 + – >40
 A3  >40 20–30 + + >40 ND ND >40
 A4  >40 30–40 + – >40 ND ND >40
Contact
 K1  >40 >40 ND ND >40 ND ND >40
 K2  >40 >40 ND ND >40 ND ND >40
*Inoculated calves received highly pathogenic influenza virus (H5N1) strain A/cat/Germany/R606/2006 (8,9); contact calves were not inoculated but were 
housed with the inoculated calves. Egg, embryonated chicken eggs; cell, MDCK cell culture; +, virus detected; –, virus not detected; ND, not done. 
†H5-specific real-time reverse transcription–PCR; results are shown as range of detected threshold cycle values. 
Table 2. Serologic testing results for highly pathogenic avian influenza virus (H5N1) in calves, Germany, 2007* 
Day postinoculation 
0 7 14 21 28 91
Calf NP† VN‡ HI§ NP VN HI NP VN HI NP VN HI NP VN HI NP VN HI
Inoculated
   A1  98 2.3 <3 90 3.3 <3 42 4 <3 26 4 <3 24 6.2 3 20 7 <3
    A2  114 0.4 <3 117 3 <3 69 5 <3 27 4 <3 22 6.2 3 18 6.7 3
    A3  118 <1 <3 90 2.7 <3 28 5.7 <3 29 5 <3 21 7 3 15 7 3
    A4  102 0.7 <3 122 2 <3 25 5.3 <3 24 5 <3 24 5.8 3 19 6.3 <3
Contact
    K1  96 1.3 <3 88 <1 <3 73 2 <3 44 4 <3 40 4.5 <3 45 5 <3
    K2  120 0.7 <3 98 2.3 <3 89 <1 <3 68 <1 <3 76 0.7 <3 50 <1 <3
*Inoculated calves received highly pathogenic influenza virus (H5N1) strain A/cat/Germany/R606/2006 (8,9); contact calves were not inoculated but were 
housed with the inoculated calves. Positive results are in boldface.
†NP, avian influenza A– blocking ELISA against nucleoprotein (Pourquier, Montpellier, France) inhibition % (<35, positive; >45, negative; 35–45, 
questionable).  
‡VN, virus neutralization test (ND100 log2); values >4 are considered positive. 
§HI, hemagglutination inhibition (log2); values >3 are considered positive. calf at 1 dpi was the result of residual inoculum cannot be 
ruled out. Although the question whether calf-to-calf trans-
mission of HPAIV (H5N1) occurs could not be deﬁ  nitely 
answered by our study, bird-to-calf transmission resulting 
in seroconversion is probable.
The incidence of clinical infections of cattle with 
HPAIV (H5N1) in disease-endemic regions should be low. 
However, our data indicate that serum from bovine spe-
cies would be a valuable source of additional information 
about transmission events, especially in regions like Asia 
and Egypt, where HPAIV (H5N1) is endemic and prob-
ability of contact between poultry and cattle is high. The 
NP-ELISA is currently the assay of choice for the evalu-
ation of bovine serum, and the VN test should be used for 
conﬁ  rmation.
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